Tofranil (Imipramine) – Patient Information for Australia

Tofranil is a brand of imipramine, a medicine from the group known as tricyclic antidepressants (TCAs). It is used to treat certain mental health conditions and, in some cases, specific bladder-related problems in children and adults. This guide explains how Tofranil works, how it’s typically used, important safety information, and what to expect when starting treatment in Australia.

If you have questions about your personal situation, always follow the advice of your treating clinician and refer to the product information leaflet supplied with your medicine.

Basic product information

How Tofranil works (mechanism of action)

Imipramine is thought to help symptoms of depression and some other conditions by affecting chemical messengers in the brain. It mainly works by:

• Blocking reuptake of neurotransmitters such as serotonin and noradrenaline, increasing their availability in the nervous system.
• Influencing several receptors (e.g., histamine and certain adrenergic receptors), which can contribute to effects like sedation and changes in heart rate.

The antidepressant benefit usually develops gradually over days to weeks rather than instantly. For some conditions (like bedwetting), responses may also appear after a period of regular use.

Pharmacokinetics (how the body handles imipramine)

Pharmacokinetics describes how the medicine is absorbed, distributed, metabolised, and eliminated. Key points include:

• Absorption: Imipramine is absorbed after oral administration.
• Distribution: It distributes throughout the body and can reach the brain.
• Metabolism: The medicine is primarily metabolised in the liver. Active metabolites may form, contributing to overall effect.
• Elimination: Excretion occurs largely through the kidneys (urine) after metabolism.
• Half-life: Imipramine has an elimination half-life that can be long enough to support once-daily or divided dosing, depending on the condition and individual response.

Because metabolism involves the liver and clearance depends on kidney function, clinicians may adjust dose in people with liver or kidney problems and monitor for side effects.

What Tofranil is used for (indications)

In Australia, Tofranil (imipramine) is used for specific medical indications. Commonly, it may be used for:

• Depression (particularly when other options are unsuitable or as clinically indicated).
• Nocturnal enuresis (bedwetting) in selected patients (typically children), under close supervision.
• Other conditions may be considered by clinicians based on the individual’s medical history and local product information.

Usage must be consistent with the relevant Australian product information and clinical guidance. If you’re unsure why you’ve been prescribed Tofranil, ask your pharmacist or prescriber.

Timing and how to take Tofranil

The timing of doses depends on the condition being treated and how you respond to the medicine. Many people take Tofranil later in the day, often at night, because it can cause drowsiness.

• Depression: Often taken once daily or in divided doses based on symptoms and tolerability.
• Nocturnal enuresis: Typically timed to support night-time control, following clinician directions.
• Try to take it at the same time each day to maintain steady levels and reduce side effects.

Do not change your dose without medical advice. If you miss a dose, follow the guidance from your clinician or the product information. In general, don’t take a double dose to “catch up”.

Food interactions

Food interactions with imipramine are usually not dramatic, but taking Tofranil with or without food may affect comfort and absorption in some people. For best tolerability:

• If it causes nausea or stomach upset, taking it after food may help.
• Keep your routine consistent (e.g., always take with food or always take without food), unless advised otherwise.

Always check with your pharmacist regarding your specific formulation and any other medicines you take.

Alcohol interactions

Avoid alcohol while taking Tofranil unless your clinician has advised it is safe. Alcohol can increase the risk of:

• Drowsiness and impaired alertness
• Dizziness and falls
• Worsened mood or sleep disruption
• Cardiovascular effects such as blood pressure changes

If you drink alcohol occasionally, discuss “what is safe for me” with your pharmacist or prescriber. The safest approach is to limit or avoid alcohol during treatment.

Medicine interactions (important)

Tofranil can interact with other medicines due to its effects on the brain, heart rhythm, liver metabolism, and blood pressure. Some interactions can be serious. Tell your pharmacist or prescriber about all medicines you use, including:

• prescription medicines
• over-the-counter medicines
• herbal products (e.g., St John’s wort)
• vitamins and supplements

Key interaction categories include:

• Other antidepressants, including MAO inhibitors or certain SSRIs/SNRIs, which may raise serotonin-related risks or affect metabolism.
• Medicines that affect serotonin (risk of serotonin syndrome with some combinations).
• Drugs that affect heart rhythm (QT prolongation), such as some antipsychotics, antiarrhythmics, and certain antibiotics.
• Medicines that can increase TCA levels by inhibiting liver enzymes (raising side effects).
• Medicines that lower blood pressure or affect circulation, potentially increasing dizziness or fainting.
• Anticholinergic medicines (may add to constipation, dry mouth, and blurred vision).
• Stimulants and thyroid medicines (can increase heart-related effects in some people).

Never start, stop, or change any other medicine without checking for interactions. Your pharmacist can do a safety check tailored to your medicines list.

Dosing: typical approach

Dose depends on the condition, age, and how well you tolerate the medicine. Imipramine is usually started at a lower dose and adjusted gradually. In children and older adults, prescribers often use extra caution.

• Start low, go slow: A gradual titration reduces side effects such as sleepiness, dizziness, and dry mouth.
• Adjust based on response: Clinicians monitor improvement and tolerability before changing dose.
• Stop safely: TCAs should not be stopped abruptly due to potential withdrawal symptoms and symptom relapse.

Important: The exact dosing schedule should follow the Australian product information and your clinician’s instructions. Because strengths and patient factors vary, it’s safest not to provide personalised dosing details here.

Safety profile and side effects

Like all medicines, Tofranil can cause side effects. Many are dose-related and may improve as your body adapts. However, some effects require urgent attention.

Common side effects

• Drowsiness or fatigue (often seen early)
• Dizziness, especially when standing
• Dry mouth
• Constipation
• Blurred vision
• Increased sweating
• Weight changes in some people
• Urinary retention (more relevant in those with prostate or bladder issues)
• Reduced appetite or stomach discomfort (varies)

Serious side effects (seek urgent medical advice)

Contact emergency services or urgent care if you experience symptoms such as:

• Chest pain, fainting, severe dizziness, or a very fast/irregular heartbeat
• Seizures
• Severe allergic reaction (swelling of face/lips, breathing difficulty, widespread rash)
• Signs of overdose or misuse (immediate medical attention is critical)
• Severe agitation, confusion, fever, tremor, or muscle stiffness (possible serotonin-related reaction in certain combinations)

Suicidal thoughts and mood changes

Antidepressants can increase the risk of suicidal thinking or behaviour in some people, particularly during the early stages of treatment or when doses change. This risk applies especially to younger people. Close monitoring by family/carers and clinicians is important.

If you or someone around you notices worsening depression, unusual behaviour, or thoughts of self-harm, seek urgent help immediately.

Practical use tips (making treatment easier)

• Plan for drowsiness: If the medicine makes you sleepy, take it in the evening and avoid driving or operating machinery until you know how you react.
• Manage dry mouth: Sip water regularly, chew sugar-free gum, and maintain good dental hygiene.
• Prevent constipation: Stay hydrated, consider dietary fibre, and ask your pharmacist about safe options if needed.
• Rise slowly: Move slowly from lying or sitting to standing to reduce dizziness.
• Keep appointments: Regular review helps track improvement and side effects.
• Don’t stop suddenly: If treatment needs to be changed or stopped, ask for a taper plan.

For bedwetting, clinicians often combine medication with behavioural strategies (e.g., bedtime routines, limiting evening fluids, and addressing constipation). Medication works best as part of a broader plan.

What to expect: onset of action and monitoring

When treating depression with imipramine, improvements in mood and sleep may take time. Many people notice some changes within the first couple of weeks, while the full benefit may take longer.

• Early period: Side effects may appear before benefits.
• Follow-up: Clinicians often schedule review after initial weeks, adjusting dose if necessary.
• Ongoing monitoring: If there are heart rhythm concerns, clinicians may arrange tests such as ECG in certain cases.

Alternative options

Treatment choices depend on the condition, age, medical history, and previous medication responses. If Tofranil is not suitable, alternatives may include:

• Other antidepressants (e.g., SSRIs or SNRIs), depending on the diagnosis and risk profile.
• Psychological therapies such as cognitive behavioural therapy (CBT) for depression.
• For nocturnal enuresis: behavioural interventions and, where appropriate, other medicines or specialist approaches.
• Supportive care (sleep hygiene, stress management, and addressing constipation) as relevant.

Discuss alternatives with a pharmacist or clinician. The “best” option is the one that balances effectiveness with safety and personal tolerability.

Market and legal context in Australia (general information)

Medicines in Australia are regulated under the Australian regulatory framework managed by the Therapeutic Goods Administration (TGA). Medicines may be classified based on risk and legal status for supply. Imipramine products such as Tofranil are generally handled according to their regulatory classification.

In Australia, pharmacy supply and counselling requirements help ensure safe use—especially for medicines with potential cardiac and neurological side effects, and where overdose risk is a concern.

For the most accurate information about supply status and product details, refer to the TGA and the specific Australian product information leaflet.

Recent guidance and monitoring considerations (what patients should know)

Safety guidance for antidepressants and TCAs in general focuses on:

• Early monitoring for changes in mood, behaviour, and suicidal thinking—particularly when starting treatment or adjusting dose.
• Awareness of drug interactions, including combinations that affect serotonin or heart rhythm.
• Cardiovascular risk assessment in people with existing heart conditions, older age, or those taking interacting medicines.
• Extra caution in children for enuresis and in any younger person treated for depression, with careful supervision and follow-up.

Your pharmacist may advise additional checks such as reviewing your medicine list for interactions and discussing side effects to watch for.

Delivery and availability (online pharmacy information)

Availability of Tofranil (imipramine) can vary by supplier and stock levels. An online pharmacy can help with ordering and delivery options across Australia. Delivery times depend on the chosen shipping method and local processing times.

• Stock status: You may see current availability at checkout.
• Packaging: Medicines are typically supplied in original packaging with labels and patient information.
• Dispatch: Dispatch occurs after processing your order and confirming payment.
• Tracking: Many orders include tracking updates.

If you need urgent treatment, contact customer support so they can check the fastest fulfilment options.

When to seek help urgently

Get urgent medical advice if you have:

• fainting, severe dizziness, or symptoms suggesting a heart rhythm problem
• severe confusion, agitation, or temperature changes
• seizures
• signs of overdose (especially if an incorrect dose is taken)
• severe allergic symptoms (swelling, breathing difficulty)

If overdose is suspected, seek emergency help immediately. In Australia you can also call the Poisons Information Centre for advice (phone numbers are commonly available via healthdirect and state health services).

FAQ – Tofranil (Imipramine)

1) How long does Tofranil take to work?

For depression, some people notice changes in sleep or mood within 1–2 weeks, but full benefit can take longer. For nocturnal enuresis, improvement may occur after starting regular use, as directed by your clinician. If you don’t notice any improvement, review your treatment plan with your doctor.

2) Why do I feel sleepy or dizzy when I start?

Tofranil can cause sedation and affect blood pressure, especially early in treatment or after dose changes. Taking it in the evening and rising slowly may help. If dizziness is severe or you feel faint, seek medical advice.

3) Can I drive while taking Tofranil?

Avoid driving or operating machinery until you know how Tofranil affects you. Drowsiness and slowed reaction time can occur, especially at the beginning of treatment.

4) Is it safe to drink alcohol?

It’s generally safest to avoid alcohol because it can increase drowsiness and worsen coordination and mood. Ask your pharmacist or clinician for personalised advice.

5) What happens if I miss a dose?

Follow the advice from your clinician or the product information. As a general rule, don’t take an extra dose to make up for a missed one unless instructed.

6) Can I stop Tofranil suddenly?

Usually, TCAs should not be stopped abruptly. Stopping suddenly can lead to withdrawal symptoms and may worsen the condition. Discuss a gradual taper plan with your clinician.

7) What side effects are most common?

Common effects include drowsiness, dry mouth, constipation, dizziness, blurred vision, and sweating. Many improve as your body adjusts, but persistent or severe symptoms should be discussed with a pharmacist.

8) Are there any foods I should avoid?

There are typically no strict food restrictions, but taking Tofranil after food may reduce nausea for some people. Keep your routine consistent unless advised otherwise.

9) Can Tofranil interact with other medicines?

Yes. Tofranil can interact with other antidepressants, medicines affecting heart rhythm, and drugs that influence liver metabolism. Always provide your full medicine list to your pharmacist for interaction checking.

10) Is Tofranil suitable for children?

Tofranil may be used for nocturnal enuresis in selected children under strict clinical supervision. Dose and monitoring are important, and parents/carers should watch for side effects and follow the treatment plan closely.

Need help choosing or understanding your medicine? Speak with a qualified pharmacist. They can explain how to take Tofranil safely, review interactions, and help you manage side effects.